HARMONY BIOSCIENCES HLDG INC (HRMY)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for HRMY
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| HRMY | Director | 67 | [] | [] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| PCRX | Director | 62 | ["life sciences entrepreneur", "investor with over 30 years of experience in the pharmaceutical and biotechnology industries", "Chief Executive Officer of HBM Healthcare Investments since 2001", "Senior Vice President of European Analytical Operations at MDS Inc. from 1998 to 2001", "co-owner and Chief Executive Officer of ANAWA Laboratorien AG and Clinserve AG from 1990 to 1998", "member of the board of directors of PharmaSwiss SA from 2007 to 2011", "held board positions on several privately-held companies and companies listed on international exchanges", "holds an M.Sc. and Ph.D. in chemistry and biochemistry from the University of Bern, Switzerland", "extensive experience with pharmaceutical companies", "financial expertise", "years of experience providing strategic and advisory services to pharmaceutical and biotechnology organizations"] | [] | 2021 |
Biography sourced from the proxy statement filing.
Andreas Wicki, Ph.D., has served on our board of directors since September 2017. Dr. Wicki has served as Chief Executive Officer of HBM Healthcare Investments AG (formerly HBM BioVentures AG) since July 2001. From 1998 to 2001, Dr. Wicki was the Senior Vice President of the European Analytical Operations at MDS Inc. From 1990 to 1998, he was co-owner and Chief Executive Officer of ANAWA Laboratorien AG and Clinserve AG, two life sciences contract research companies. Dr. Wicki currently serves on the board of directors of Buchler GmbH, HBM Healthcare Investments (Cayman) Ltd., HBM BioCapital Ltd., Viela Bio, Inc., a public clinical-stage biotechnology company, and Vitaeris, Inc., a private clinical-stage biopharmaceutical company. Dr. Wicki previously served on the board of Pacira BioSciences, Inc., a public pharmaceutical company from 2006 until January 2025. Dr. Wicki is a life sciences entrepreneur and investor with over 30 years of experience in the pharmaceutical and biotechnology industries. Dr. Wicki holds an M.Sc. and Ph.D. in chemistry from the University of Bern, Switzerland. We believe Dr. Wicki is qualified to serve on our board of directors due to his extensive experience with pharmaceutical companies, his financial expertise and his years of experience providing strategic and advisory services to pharmaceutical and biotechnology organizations.